Dr. Fischell is Professor of Medicine at Michigan State University and Medical Director of the Department of Cardiovascular Research as well as Director of the Interventional Cardiology Fellowship Program at the Borgess Heart Institute in Kalamazoo, Michigan. He also has an active practice as an interventional cardiologist at the Borgess Heart Institute in Kalamazoo, MI.
After receiving his medical degree from Cornell University Medical Center in New York City, Dr. Fischell completed an internship and residency in internal medicine at Massachusetts General Hospital/Harvard University in Boston, and then completed his interventional cardiology fellowship at Stanford University Medical Center in Palo Alto, California. He was on the faculty at Stanford for five years, and then director of the cardiac cath labs and interventional cardiology at Vanderbilt University from 1992-1996. Dr. Fischell is board certified in internal medicine, cardiovascular medicine and interventional cardiology.
He has served as principal investigator for 3 National Institutes of Health grants, as well as several other research grants. Dr. Fischell has research interests in vascular biology, interventional cardiology devices such as stents and renal denervation, and has presented more than 200 papers in the United States and abroad.
A member of the editorial board of Cardiovascular Revascularization Medicine, Journal of Invasive Cardiology, and the Journal of Interventional Cardiology Dr. Fischell has authored more than 120 publications in peer-reviewed journals and more than 27 book chapters.
Dr. Fischell is the inventor or co-inventor of more than 80 patented medical devices. He is founder or co-founder of ~10 medical device companies, and is currently founder and CEO of Ablative Solutions, Inc. He has received awards, including the Thorax Center Andreas Gruentzig Award for Inventor of the Year in 1997 and the CRT 2015 Innovation Award.